Directory of Genetic Counselors Is Available

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 7
Volume 6
Issue 7

BETHESDA, Md--A directory of genetic counselors, physicians, geneticists, and nurses who have expertise in counseling about familial risk for cancer and testing for genetic susceptibility is available on CancerNet, an online cancer information service developed and maintained by the NCI's International Cancer Information Center (ICIC).

BETHESDA, Md--A directory of genetic counselors, physicians, geneticists,and nurses who have expertise in counseling about familial risk for cancerand testing for genetic susceptibility is available on CancerNet, an onlinecancer information service developed and maintained by the NCI's InternationalCancer Information Center (ICIC).

"The directory will help health care professionals who are increasinglyin need of locating qualified cancer counseling and testing referral resourcesfor their patients," said Susan Molloy Hubbard, RN, MPA, directorof the ICIC.

Qualifications Given

The directory may be accessed by name, city, state, county, and typeof cancer or cancer gene. The resource provides information on the degrees,institutional affiliations, professional licenses, and certification ofthe counselors. More than 200 counselors are currently listed.

The Internet URL for CancerNet is http://cancernet.nci.nih.gov. Qualifiedhealth care professionals who wish to be added to the directory may sendan e-mail query to genetics@icic.nci.nih.gov, or fax a request to the GeneticCounseling Directory at 301-402-6728.

Recent Videos
Patients with cancer are subjected to fewer radiotherapy-induced toxicities because of newer, more advanced technologies.
Hosts Manojkumar Bupathi, MD, MS, and Benjamin Garmezy, MD, discuss presentations at ESMO 2025 that may impact bladder, kidney, and prostate cancer care.
Mandating additional immunotherapy infusions may help replenish T cells and enhance tumor penetration for solid tumors, including GI malignancies.
A novel cancer database may assist patients determine what clinical trials they are eligible to enroll on and identify the next best steps for treatment.
Receiving information regarding tumor-associated antigens or mutational statuses from biopsies may help treatment selection in GI malignancies.
An easy-to-access database allows one to see a patient’s cancer stage, prior treatment, and survival outcomes in a single place.